CSTL: TissueCypher's rapid growth and AI-driven advances position the business for strong future expansion
Strong Q2 growth was driven by TissueCypher's 63% YoY volume increase and robust gross margins, with long-term market penetration modeled at 60%-65%. AI initiatives are enhancing test development and reimbursement, while new product launches and reimbursement milestones are expected to drive future…